Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

New accessible playground opens in Saskatoon

September 11, 2026

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026

Mark Carney meets with ‘Forever Canadian’ campaigners in Banff

September 11, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint
Press Release

Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint

By News RoomJanuary 21, 20268 Mins Read
Jushi Holdings Inc. Announces Grand Opening of Second Beyond Hello™ in Cincinnati, Ohio, Expanding its Statewide Retail Footprint
Share
Facebook Twitter LinkedIn Pinterest Email
  • Seventh Retail Location in Ohio and 43rd Nationwide
  • New Dispensary Opened January 8, 2026, in Northern Cincinnati
  • Grand Opening Celebration January 23, 2026, Featuring Exclusive Promotions

A Media Snippet accompanying this announcement is available by clicking on this link.

BOCA RATON, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) — Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, today announced the grand opening of its Beyond Hello™ Northern Cincinnati dispensary, located at 12140 Springfield Pike, Cincinnati, OH 45246. This marks the 7th Beyond Hello location in the state of Ohio—joining Parma, Toledo, Oxford, Warren, Mansfield, and its existing Cincinnati-area location—and the Company’s 43rd operating retail location nationwide.

The new dispensary officially opened its doors on Friday, January 8, 2026. Customers can place online reservations for in-store pickup at beyond-hello.com. For additional information, the store can be reached directly at (937) 504-2002.

Conveniently located along the Springfield Pike corridor, Beyond Hello™ offers easy access for residents and commuters across the greater Cincinnati area, including surrounding neighborhoods and nearby communities. The location features ample parking and a thoughtfully designed retail environment intended to deliver a smooth, welcoming customer experience.

The store will offer a wide selection of premium cannabis products, including flower, vapes, concentrates, edibles, and wellness options. As with all Beyond Hello™ locations, customers will be supported by a knowledgeable team of cannabis professionals committed to education, personalized service, and an elevated retail experience.

01-21-2026 Springdale OH retail floor

To celebrate the opening, Beyond Hello™ will feature special grand opening promotions for patients and adult-use customers beginning January 23, 2026.

“Ohio continues to be one of our most strategic growth markets, and the opening of our second Beyond Hello in the Cincinnati area represents another important milestone in our expansion across the state,” said Jim Cacioppo, Chief Executive Officer, Chairman, and Founder of Jushi Holdings Inc. “With a strong medical foundation and a rapidly evolving adult-use market, Ohio offers a compelling long-term opportunity. We’re proud to deepen our presence in the Cincinnati area and to provide consumers with a trusted, high-quality retail experience rooted in care, education, and community.”

Jushi continues to expand its vertically integrated operations in Ohio, where it cultivates and manufactures a portfolio of in-house brands including Hijinks, The Bank, SeCHe, The Lab, and Tasteology. By expanding its retail footprint, the Company is increasing access to safe, regulated cannabis products while reinforcing its long-term commitment to Ohio’s fast-growing cannabis market.

For more information, visit beyond-hello.com or follow Beyond Hello™ on social media.

01-21-2026 Springdale OH Tasteology

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by an industry-leading management team. Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, distressed workouts, and competitive applications. Jushi strives to maximize shareholder value while delivering high-quality products across all levels of the cannabis ecosystem. For more information, visit jushico.com or our social media channels, Instagram, Facebook, X, and LinkedIn.

Forward-Looking Information and Statements

This press release may contain “forward-looking statements” and “forward‐looking information” within the meaning of applicable securities laws, including Canadian securities legislation and United States (“U.S.”) securities legislation (collectively, “forward-looking information”) which are based upon the Company’s current internal expectations, estimates, projections, assumptions and beliefs. All information, other than statements of historical facts, included in this report that address activities, events or developments that the Company expects or anticipates will or may occur in the future constitutes forward‐looking information. Forward‐looking information is often identified by the words, “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes, among others, information regarding: future business strategy; competitive strengths, goals, expansion and growth of the Company’s business, operations and plans, including new revenue streams; the refinancing or securing other sources of liquidity to meet debt repayment obligations; the implementation by the Company of certain product lines; the implementation of certain research and development; the application for additional licenses and the grant of licenses that will be or have been applied for; the expansion or construction of certain facilities; the reduction in the number of our employees; the expansion into additional U.S. and international markets; any potential future legalization of adult use and/or medical marijuana under U.S. federal law; expectations of market size and growth in the U.S. and the states in which the Company operates; expectations for other economic, business, regulatory and/or competitive factors related to the Company or the cannabis industry generally; and other events or conditions that may occur in the future.

Readers are cautioned that forward‐looking information is not based on historical facts but instead is based on reasonable assumptions and estimates of the management of the Company at the time they were provided or made and such information involves known and unknown risks, uncertainties, including our ability to continue as a going concern, and other factors that may cause the actual results, level of activity, performance or achievements of the Company, as applicable, to be materially different from any future results, performance or achievements expressed or implied by such forward‐looking information. Such factors include, among others: the limited operating history of the industry and the Company; risks related to managing the growth of the Company including completed, pending or future acquisitions or dispositions, including potential future impairment of goodwill or intangibles acquired and/or post-closing disputes; risks related to the continued performance, expansion and/or optimization of existing operations in California, Illinois, Massachusetts, Nevada, New Jersey, Ohio, Pennsylvania, and Virginia; risks related to the anticipated openings of additional dispensaries or relocation of existing dispensaries subject to licensing approval; the Company’s history of operating losses and negative operating cash flows; increasing competition in the industry; risks inherent in an agricultural business, such as the effects of natural disasters; reliance on the expertise and judgment of senior management of the Company; risks associated with cannabis products manufactured for human consumption including potential product recalls; limited research and data relating to cannabis; constraints on marketing products; risk of litigation; insurance-related risks; public opinion and perception of the cannabis industry; risks related to the economy generally; fraudulent activity by employees, contractors and consultants; risks relating to the Company’s current amount of indebtedness; risks relating to not being able to reduce or refinance its debt obligations; reliance on key inputs, suppliers and skilled labor, and third party service provider contracts; reliance on manufacturers and contractors; risks of supply shortages or supply chain disruptions; risks relating to pandemics and forces of nature; risks related to the enforceability of contracts; risks related to inflation, the rising cost of capital, and stock market instability; risks relating to U.S. regulatory landscape and enforcement related to cannabis, including political risks; risks relating to anti‐money laundering laws and regulation; cannabis-related tax risks and challenges from governmental authorities with respect to the Company’s application for Employee Retention Tax Credits (ERC); other governmental and environmental regulation; risks related to proprietary intellectual property and potential infringement by third parties; sales of a significant amount of shares by existing shareholders; the limited market for securities of the Company; risks relating to the need to raise additional capital either through debt or equity financing; costs associated with the Company being a publicly-traded company and a U.S. and Canadian filer; risks related to co‐investment with parties with different interests to the Company; conflicts of interest and related party transactions; cybersecurity risks; and risks related to the Company’s critical accounting policies and estimates. Refer to Part I – Item 1A. Risk Factors in the Company’s Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission on March 6, 2025 for more information.

Although the Company has attempted to identify important factors that could cause actual results to differ materially, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such forward‐looking information will prove to be accurate as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on the forward‐looking information contained in this press release or other forward-looking statements made by the Company. Forward‐looking information is provided and made as of the date of this press release and the Company does not undertake any obligation to revise or update any forward‐looking information or statements other than as required by applicable law.

Unless the context requires otherwise, references in this press release to “Jushi,” “Company,” “we,” “us” and “our” refer to Jushi Holdings Inc. and our subsidiaries.

For further information, please contact:

Jushi Investor Relations
Trent Woloveck
Co-Chief Strategy Director
614-271-4349
[email protected]
[email protected]

Photos accompanying this announcement are available at:

https://www.globenewswire.com/NewsRoom/AttachmentNg/d782d949-1756-40d0-8b4b-182c2a406855
https://www.globenewswire.com/NewsRoom/AttachmentNg/a6213672-c6e6-4182-b723-c73cbdc996dc
https://www.globenewswire.com/NewsRoom/AttachmentNg/6a8d93bf-91d3-4436-90c6-d026741d5a79

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

The GLP-1 Boom Is Bypassing Latino Patients; Bilingual Telehealth Clinic Sol y Vida Launches to Change That

California Waste Solutions Approaches 35 Years of Recycling and Global Environmental Infrastructure

“BEYOND THE EXTREME" Digital Music Night Debuts at ICEBAR Stockholm

SALOMON AND IRONMAN ANNOUNCE LONG-TERM PARTNERSHIP, TAKING ENDURANCE WHERE IT GOES NEXT

Erica Zarkovich, Chief Market and Partnerships Officer, Named One of Canada’s Most Powerful Women: Top 100

HII is Awarded Long-Lead Time Materials Contract for CVN 82

Crypto News Today: MemeToro Leaves Solana and XRP Behind as Presale Moves Toward Stage 7 Sellout

Omniscient Secures Third FDA Clearance, Extending Its Connectomic Platform into the Fast-Growing Deep Brain Stimulation Market

Editors Picks

Stellantis signs MOU on Brampton, Ont., plant as talks with union break down

September 11, 2026

Dawson community marks 20 years since college shooting

September 11, 2026

Lethbridge firefighters honoured at annual memorial: ‘What we signed up to do’

September 11, 2026

Mark Carney meets with ‘Forever Canadian’ campaigners in Banff

September 11, 2026

Latest News

Ikea supersized its cheap Bluetooth speaker and added an optical input

September 11, 2026

FDA Approves Isembyld (apitegromab-mstn), the First and Only Muscle-Targeted Therapy for Spinal Muscular Atrophy, Marking a New Milestone in SMA Treatment

September 11, 2026

Lake Ontario merchandise turns Trump order into fundraiser to protect the lake

September 11, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version